Reproductive Endocrinology

CEBRO

CEBRO is a dual-coenzyme formulation designed to prevent metabolic stall and support maternal health.

Active Clinical Composition: Vitamin B1, B6, B12, L-Methylfolate, and Vitamin D3
(2 customer reviews)

₨ 795

Pharmacodynamics & Mechanism of Action: CEBRO is a dual-coenzyme formulation designed to prevent metabolic stall and support maternal health. It operates through the following pathways:

  • Active B12 (Methylcobalamin, 1000mcg): Provides maternal vitality and nerve support. It reverses megaloblastic anemia and gestational fatigue, while offering non-NSAID relief for pregnancy-induced sciatica and nerve compression.

  • Active Folate (L-Methylfolate, 400mcg): Acts as an obligate synergist. As a pre-activated molecule, it completely bypasses enzymatic bottlenecks and prevents the “Folate Trap” by forcing the remethylation of homocysteine.

  • Vitamin B6 (3mg): Safely flushes neutralized homocysteine out of the maternal system to prevent toxic buildup.

  • Vitamin B1 (5mg): Acts as a neuromuscular synergist that accelerates relief from pregnancy-induced sciatica.

  • Vitamin D3 (400 IU): Provides guideline-mandated prophylactic defense for maternal and fetal bone mineral density.

  • CEBRO is indicated for the following clinical parameters:

    • Gestational Sciatica & Lumbar Pain: Provides targeted non-NSAID relief. It soothes lumbosacral nerve compression caused by shifting pelvic biomechanics and fetal weight, offering a safe alternative when NSAIDs are contraindicated. The 1000mcg payload safely and rapidly relieves lumbosacral nerve compression, unlike legacy monotherapy (500mcg) which acts only as slow maintenance and is sub-therapeutic for acute pregnancy pain.

    • Megaloblastic Anemia & Fatigue: Delivers simultaneous high-potency coenzymes to correct megaloblastic anemia, resolve severe gestational exhaustion, and restore maternal energy. This dual-coenzyme delivery guarantees uninterrupted red blood cell maturation, whereas standalone B12 is often a diagnostic gamble and ineffective due to concurrent folate deficits.

    • Recurrent Pregnancy Loss (RPL): Provides placental vascular defense by bypassing genetic MTHFR bottlenecks to clear embryotoxic homocysteine. This protects delicate micro-vascular blood flow to the developing placenta, addressing the incomplete clearance and vascular risk seen with legacy monotherapy.

Active SubstanceStrength per Unit
Vitamin B15mg
Vitamin B63mg
Active Vitamin B12 (Methylcobalmin)1000mcg
Active Vitmain B9 (L-Methylfolate)400mcg
Vitamin D3400IU

* Excipients and coating agents not listed. Refer to full SMPC for complete profile.

  • Dosage: One (1) tablet daily, or as directed by a registered medical practitioner.

  • Administration: Swallow whole.

  • Dose Adjustment: Dosage may be titrated per clinical discretion for severe sciatica.

  • Safety Alignment & Precautions (NIH/NICE): Global guidelines explicitly warn that standalone folate can mask underlying B12 deficiency (silent neurological masking) and risk a metabolic stall (Folate Trap). CEBRO locks 400mcg Active Folate strictly with a 1000mcg B12 safeguard to ensure risk-free remethylation and fully align with clinical safety mandates.

  • Contraindications: CEBRO is utilized as a safe therapeutic alternative specifically when NSAIDs are contraindicated for pain relief.

2 reviews for CEBRO

  1. Avatar Of Fayaz Ullah

    Fayaz Ullah –

    Cebro has been a remarkable nerve booster for me. Its blend of vitamins and minerals has noticeably supported my cognitive functions and nervous system health. I feel more alert and focused, and it’s comforting to know I’m taking care of my neurological well-being.

  2. Avatar Of Brian

    Brian –

    Top quality product. Recommend 10/10

Add a review

Your email address will not be published. Required fields are marked *

Scientific Literature & Global Guidelines
  1. American College of Obstetricians and Gynecologists. (2021). ACOG Practice Bulletin No. 233: Anemia in Pregnancy. Obstetrics & Gynecology, 138(2), e55-e64.
  2. National Institute for Health and Care Excellence. (2024). Vitamin B12 deficiency in over 16s: diagnosis and management (NICE Guideline NG239).
  3. National Institute for Health and Care Excellence. (2021). Antenatal care (NICE Guideline NG201).
  4. Royal College of Obstetricians and Gynaecologists. (2023). Recurrent Miscarriage (Green-top Guideline No. 17).
  5. Nelen, W. L., Blom, H. J., Steegers, E. A., den Heijer, M., Thomas, C. M., & Eskes, T. K. (2000). Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. American Journal of Obstetrics and Gynecology, 182(6), 1436-1443.

To report an adverse event or product complaint, contact the Hunoir Pharmaceuticals Medical Affairs Department.